Minnie.... I just think that the gram positive space is getting pretty crowded. At some level DRTX has to be a buyout just to round out an antibiotic portoflio for a big pharma. $23-$26 I think could be a tad optimistic, but
$18-$20, definitely in the ballpark. I would be more optimistic on a NT buyout if the once per week and done application was already approved. Going back for one more injection on day 8 just isn't convenient but DRTX has already addressed that issue in a timely manner and is on the right track to remedy it.
I also personally like the idea of an oral step down type antibiotic rather than a multiple injection one, but if you're dealing with a one and done injection like DRTX it really doesn't matter does it?
At current levels I like and own CEMP in the gram positive space as it has come way down from its
highs and IMHO is under owned and under followed. May take some time but I like the risk/reward in that name and the areas they are addressing.
TTPH is in the gram negative space so an entirely different ballgame. That's the tough to cure stuff.
Also own AKAO in that same space.
Minnie.... I love DRTX and have since it was $7 (and thankfully sold it a $16.73 avg. as I posted here at the time I did it). With all due respect, you have no idea how tough it is to "go it alone" in the medical products field. Just ask the shareholders of AMRN...$18 to $1.
To go up against a CBST and some others, who have the bundling of products advantage over a lone
product supplier, is very tough. That is why DRTX is well suited to be acquired. Big pharma is likely to see how sales go and if DRTX can pull off going it alone before making any offer. And CBST can't buy everyone and they're still trying to get TSRX up and running...lol....Right now I would not look for any buyout offers frankly.
I should have taken my 1 1/2 point loss in SODA when it rallied a few days ago on apparently false going private rumors....LOL Now back to a 6 pt. loss...Oh well....
MDWD not doing so hot either...LOL!
Why do people post about shorts and "shorties" when a stock drops? I mean you see it on every Board with one moronic post after another about "shorts". The FACTS are that the short shares outstanding in DRTX are the lowest now since March, 2014. But let's not let facts get in the way of total nonsense should we?
IMHO once, or if, they announce a secondary...I will reload the boat huge. Risk then basically taken out of the stock IMHO...At least for the near term....
Sorry....,didn't bother to proof read my post....
1. "following" approval not "forllowing" (sic)
2. Meant "gram positive", not gram negative space.
What is so "inexplicable" about the drop in price from $18?
Really... Try a few...
1. The stock was very near term over bought thanks to the multitude of Johnny come lately mo mo
and "buy out" hype buyers who were basically clueless about what the company even does, or the markets
they address. When the buyout didn't take place within a couple of months forllowing approval, most of those folks moved on to the next "hot" one, and out of DRTX.
2. No marketing partner as yet.
3. Intense pricing competition now in the gram negative space from many of the larger players such as
CBST, whose lastest earnings actually missed as well. Bundling products to discount some new antibiotics such as those coming from TSRX, whom they acquired last year.
4. Prospects of a secondary I feel are very real and probably sooner than later. Need to raise cash to fund
a "going it alone" marketing strategy both here, and in Europe, requires some fairly hefty up front costs.
Going up against a CBST is not easy task for any under funded small bio with no marketing partner.
5. Bios have been weak of late in general thanks to the earlier comments by Yellen. Antibiotic group has been hit hard...CBST...82-61; TTPH...18-11; CEMP...15-9; AKAO....19-10;
6. No news forthcoming from the company re early sales uptake; marketing partner potential;
7. Research coverage has really not issued anything of substance either.
8. Technicals...look frankly terrible. Would not want to see the stock break 12.20 NT...
Downside to high 10's to low 11's very possible if they announce a secondary or any other
major news that could be considered "negative".
They still love me over on the Siga Board...Especially "Siga Board Patrol" who continues to stalk me on every site I post on with thumbs down...LOL! What a nut job...LOL!
I know that...I never said you did. You told me to buy SODA around $45...then $42...then $38.. and all the way down to $32. I bought some around $38...then $36...then a little at $33....Avg. $35 ish...
Just commenting on SODA in general... I never blame anyone for any of my losses, nor ever #$%$ about them frankly.
ROD...I'm still down 1 1/2pts on SODA so not quite celebrating yet but it's looking alot better...lol!
MDWD...It's located in Israel....I read somewhere they were having problems recently so probably have to wait until the rockets quit falling from the sky to improve market sentiment...lol! Seriously...They have a great and much needed product to treat serious burns, but they have to get it approved here first (it's approved in Europe) to expand the market tenfold.
Looks like they may be going private according to the release. Up 18% today alone. $34 right now.
Averaged down a bit but still need another 1 1/2 pts to breakeven! Good job...
To me the stock has been trading like a secondary is in the works. IMHO... The stock ran up on some upgrades and those COULD be the potential underwriters... Unless there is a buy out the company will need to raise money to fund a large sales force...mfg....marketing/advertising.....etc. Maybe not tomorrow, but down the road pretty soon... I went through a going it alone FDA approved drug company and it ended up in disaster, so a buyout would be far better IMHO for shareholders.... Sold in the high 16's from buys in the 7's,
and will likely re-enter the stock once the issue of funding is alot clearer to me.... Love the antibiotic though!GLTALs!